Oncology Today with Dr Neil Love

Latest Episodes:

Chronic Lymphocytic Leukemia — Year in Review Series on Relevant New Datasets and Advances May 02, 2025

Show notes

Dr Jennifer R Brown from Dana-Farber Cancer Institute in Boston and Prof Paolo Ghia from IRCCS Ospedale San Raffaele in Milano, Italy, summarize clinically relevant research findings and datasets over the past year regarding the treatment of chronic lymphocytic leukemia.

CME information and select publications here.

EGFR Mutation-Positive NSCLC — Fourth Annual National General Medical Oncology Summit Apr 30, 2025

Show notes

Clinical investigators discuss available data guiding the management of EGFR mutation-positive non-small cell lung cancer. 

CME information and select publications here.

Prostate Cancer — Fourth Annual National General Medical Oncology Summit Apr 29, 2025

Show notes

Clinical investigators discuss available data guiding the management of prostate cancers. 

CME information and select publications here.

Immune Thrombocytopenia — A Roundtable Discussion on Current and Future Management Strategies Apr 28, 2025

Show notes

Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston, Dr James B Bussel from Weill Cornell School of Medicine in New York, New York, and Prof Nichola Cooper from Hammersmith Hospital Campus in London, United Kingdom, share expert perspectives on the diagnosis of and optimal management strategies for immune thrombocytopenia.

CME information and select publications here.

Biliary Tract Cancers — Fourth Annual National General Medical Oncology Summit Apr 27, 2025

Show notes

Clinical investigators discuss available data guiding the management of biliary tract cancers. 

CME information and select publications here.

For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress Apr 26, 2025

Show notes

Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug conjugates in the care of patients with breast and lung cancer and strategies to mitigate and manage treatment-emergent adverse events.

NCPD information and select publications here.

Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy Apr 23, 2025

Show notes

Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer and preexisting medical conditions.

CME information and select publications here.

Genitourinary Cancers — An Interview with Dr William K Oh on Recent Trial Updates Apr 23, 2025

Show notes

Dr William Oh from the Yale Cancer Center in New Haven, Connecticut, discusses recent updates on available and novel treatment strategies for genitourinary cancers.

CME information and select publications here.

Relapsed/Refractory Follicular Lymphoma Part 1 — A Roundtable Discussion on the Selection and Sequencing of Bispecific Antibodies Apr 22, 2025

Show notes

Dr Carla Casulo from Wilmot Cancer Institute in Rochester, New York, Dr Matthew Matasar from Rutgers Cancer Institute of New Jersey in New Brunswick and Dr Laurie H Sehn from BC Cancer Centre for Lymphoid Cancer in Vancouver discuss recent updates on available and novel treatment strategies for relapsed/refractory follicular lymphoma.

CME information and select publications here.

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit Apr 21, 2025

Show notes

Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. 

CME information and select publications here.